The zebrafish is an attractive vertebrate model for genetic studies of development, apoptosis, and cancer. Here we describe a transgenic zebrafish line in which T-and Blymphoid cells express a fusion transgene that encodes the zebrafish bcl-2 protein fused to the enhanced green fluorescence protein (EGFP). Targeting EGFP-bcl-2 to the developing thymocytes of transgenic fish resulted in a 2.5-fold increase in thymocyte numbers and a 1.8-fold increase in GFP-labeled B cells in the kidney marrow.
Introduction
Apoptosis is a critical mechanism for regulating homeostasis and tissue remodeling during development. Thus, it is not surprising that many of the molecular components and pathways regulating this process have been conserved throughout evolution. [1] [2] [3] [4] Apoptosis is also essential for hematopoietic cell development in vertebrates. 5, 6 For example, regulated programmed cell death is critical for the maintenance of hematopoietic stem cell number 7, 8 and for normal T-lymphocyte development.
9-12
Failure of lymphoid cells to undergo cell death can contribute to oncogenic transformation, and in fact, the suppression of apoptosis through key mutations in one or more regulatory pathways is often a critical component of malignant transformation. [13] [14] [15] [16] Although many of the molecular pathways that regulate apoptosis are shared among vertebrate and non-vertebrate organisms, evolution has led to increased complexity in the pathways regulating programmed cell death in higher organisms.
Unlike worms and flies, vertebrates have multiple anti-apoptotic and pro-apoptotic Bcl-2 family members. 17 Thus, it is not surprising that loss of function studies in mice have demonstrated tissue-specific roles for many of these proteins, and in other cases have suggested redundant functions due to the expression of more than one family member.
9, 10, [18] [19] [20] [21] [22] [23] Given the remarkable complexity associated with the control of apoptosis in vertebrates, new insights may be gained from studying cell death pathways in vertebrate forward-genetic model systems, such as the zebrafish.
Vertebrate evolution has resulted in the development of new organ systems, thus regulation of cell death pathways within vertebrate-specific tissue types cannot be directly studied in invertebrate species. Although Drosophila have blood cells, they do not have the same blood cell lineages as vertebrates and many of the tissues that regulate vertebrate blood formation are absent in flies, 24 including the thymus and marrow. Thus, the regulation of cell death pathways in T and B cells cannot be studied directly in genetically tractable invertebrate models. By contrast, zebrafish have conserved genetic programs underlying vertebrate blood development, 25 and like their mammalian counterparts, fish have both T and B cells. [26] [27] [28] Finally, many of the genes that regulate apoptosis in the zebrafish appear to be conserved in mammals. 29 Zebrafish homologues of bad 30 , bax 29 , bcl-xL 31 , mcl-1 32 , caspase-3 33 , caspase-8 and noxa have been identified; however, few studies have addressed the ability of the zebrafish proteins to suppress or induce apoptosis in vivo.
Here we report the identification and functional analysis of the zebrafish bcl-2 homologue. We show that a chimeric fusion protein between zebrafish bcl-2 and the enhanced green fluorescent protein (EGFP) is able to block irradiation-and dexamethasone-induced apoptosis when targeted to the lymphocytes. Transgenic rag2-EGFP-bcl-2 fish have increased numbers of thymocytes and B cells when compared to control fish. Finally, Myc-induced leukemias can be ablated by -irradiation, but EGFPbcl-2 expressing leukemias are resistant to irradiation-induced apoptosis. Thus, bcl-2-mediated suppression of apoptosis in thymocytes is remarkably conserved in zebrafish compared to mammals. Studies in the zebrafish may lead to new insights into the mechanisms by which B and T lymphocytes undergo cell death during lymphocyte development.
Materials and methods

Animals
Zebrafish maintenance and developmental staging were conducted as described previously.
34,35
Cloning of the zebrafish bcl-2 gene A degenerate polymerase chain reaction (PCR) strategy was used to isolate a fragment of the zebrafish bcl-2 cDNA. RNA was extracted from 6, 24, and 96 hour embryos (Trizol, GibCo BRL) and cDNA fragments were generated by reverse transcription. Degenerate PCR primers (Forward: GAYGGIGTIAAYTGRGGIMGIAT;
Reverse: CAICCICCRTTITCYTGIATCCA) amplified a 167 nucleotide fragment which was cloned into Bluescript SK and sequenced. A full-length clone was obtained by
screening an embryo cDNA library (RZPD). Protein sequence comparisons were completed using GCG and the Jotun Hein algorithm in the MEGALIGN program of the DNA STAR sequence analysis software package.
Transgene construction
The zebrafish bcl-2 open reading frame was amplified by PCR and cloned into the EGFP-C1 vector (Clontech). The forward primer contained a SalI enzyme site and altered the methionine start site of bcl-2, changing the amino acid to a leucine. The reverse primer contained the bcl-2 translation stop sequence and a HindIII site. The PCR purified fragment was digested with SalI and HindIII and subsequently cloned in the XhoI and HindIII digest sites of the EGFP-C1 vector. Clones containing inserts were sequenced fully.
In order to place the EGFP-bcl-2 fusion gene into the rag2 promoter-containing vector, we again used a PCR-mediated cloning strategy. The forward primer contained a
BamHI site upstream of the EGFP Kozak sequence and the reverse primer contained the bcl-2 translation stop sequence followed by a HindIII site. The PCR fragment was digested with BamHI and HindIII, and ligated into the rag2 promoter-containing vector using the same restriction digest sites. 36 The rag2-EGFP-bcl-2 construct was sequenced to verify that PCR did not introduce point mutations.
The rag2-EGFP-bcl-2 vector was digested with ClaI and BamHI, releasing the EGFP-bcl-2 coding sequence fragment, which was subsequently cloned into the pCS2+ vector using these same restriction digest sites.
RNA rescue experiments
In vitro transcription reactions were used to generate GFP and EGFP-bcl-2 RNA.
Specifically, the pCS2+GFP or pCS2+EGFP-bcl-2 vectors were digested with NotI, phenol:chloroform extracted, and ethanol precipitated. Linearized DNA was used in in vitro transcription reactions using SP6 RNA polymerase. RNA was diluted to 200 ng/µl and injected into embryos at the one-cell-stage of development. To quantitate developmental apoptosis, uninjected and GFP-positive injected embryos were analyzed for TdT-mediated dUTP-X nick end labeling (TUNEL staining, performed as described in 37, 38 ) at 16 hours post-fertilization (hpf), and the number of apoptotic cells per embryo was determined using microscopic analysis (n = 12 per group). 
Generation of stable transgenic lines
The rag2-EGFP-bcl-2 vector was digested with NotI or XhoI and injected into AB-strain embryos essentially as described. 34 One stable transgenic rag2-EGFP-bcl-2 line was identified. The rag2-GFP and rag2-EGFP-mMyc transgenic zebrafish lines have been described previously.
34
Immunocytochemistry and RNA in situ hybridization on paraffin-embedded sections Paraffin embedding and sectioning, in situ hybridization, and immunohistochemical analysis were performed essentially as described. 34 cDNA probes were made by PCR amplification of genomic DNA containing coding sequences for rag1
and rag2, using primers containing T7 and SP6 promoter sequences. PCR primers and cycling conditions have been described previously.
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T-and B-cell ablation by -irradiation
Six-day-old rag2-GFP and rag2-EGFP-bcl-2 transgenic embryos were administered a whole-body dose of -irradiation (15 Gy from a 137
Cs source) and analyzed for GFP expression within the thymus at 1-, 2-, and 3-days post-treatment.
Adult rag2-GFP and rag2-EGFP-bcl-2 transgenic fish were administered a whole-body 
T-cell ablation by dexamethasone
Five-day-old rag2-GFP and rag2-EGFP-bcl-2 transgenic embryos were treated with dexamethasone: 250 µg/ml (1% ethanol) and 100 µg/ml (0.4% ethanol) or with ethanol vehicle alone (1% or 0.4%) in egg water (60 mg/liter instant ocean in distilled water containing methylene blue). Fish were analyzed at 3-and 4-days post-treatment for T-cell ablation as detected by loss of GFP fluorescence in the thymus.
EGFP-bcl-2 blocks irradiation-induced death in Myc-induced tumors
Two classes of Myc-induced T-cell acute lymphoblastic leukemias (T-ALL) were generated: i) GFP-labeled or ii) GFP-labeled and expressing the zebrafish bcl-2 protein.
GFP labeled T-ALLs were obtained from the rag2-EGFP-mMyc stable transgenic line described previously 34 
Results
The zebrafish bcl-2 protein is highly evolutionarily conserved
The zebrafish bcl-2 protein shares a high level of amino acid similarity with other BCL-2 family members, particularly within the BH1-BH4 functional domains (Supplemental Figure 1A , B). Phylogenetic analysis places the zebrafish gene with other BCL-2 homologues (Supplemental Figure 1C) , while the previously identified bcl-xLlike protein 1 (zfBLP1) is most similar to other BCL-xL homologues, indicating that we have likely identified the bcl-2 orthologue in the zebrafish (GenBank accession # AY695820).
EGFP-bcl-2 blocks developmentally-regulated and irradiation-induced apoptosis
In order to determine if zebrafish bcl-2 has similar functions as the mammalian anti-apoptotic BCL-2 family members, we injected embryos at the one-cell-stage of Irradiation-induced apoptosis is also suppressed by EGFP-bcl-2 expression during development. GFP-positive embryos, as well as uninjected control embryos, were irradiated (15 Gy) at 14 hpf and analyzed by whole-mount TUNEL staining at 20 hpf.
EGFP-bcl-2-expressing embryos had fewer apoptotic cells than GFP-expressing or uninjected control fish (n = 12 per treatment group) following irradiation treatment (p = 0.0006 and p = 0.0002, respectively, Supplemental Figure 2 ). In fact, the expression of EGFP-bcl-2 reduced the numbers of apoptotic cells to levels equivalent to those of uninjected, unirradiated wild-type embryos (Supplemental Figure 2E ). Taken together, these results indicate that the EGFP-bcl-2 fusion protein inhibits apoptosis and that its expression can be monitored by fluorescent microscopic analysis.
EGFP-bcl-2 expressing thymocytes are not ablated by irradiation or dexamethasone treatment
To test whether zebrafish thymocytes that overexpress bcl-2 are susceptible to irradiation-and chemical-induced apoptosis, we generated rag2-EGFP-bcl-2 and rag2-GFP transgenic fish and treated them with both irradiation and dexamethasone. Because thymocyte development can be easily monitored by fluorescent microscopic analysis in larval and adult rag2-GFP and rag2-EGFP-bcl-2 fish, T-cell ablation can be discerned by loss of externally visible GFP-positive cells within the thymi of living fish. 39 Larval rag2-GFP and rag2-EGFP-bcl-2 fish were either irradiated (15 Gy on 6 dpf) or treated with dexamethasone (100 µg/ml on 5 dpf) and analyzed for GFP fluorescence within the thymus. Both treatments led to the loss of fluorescent-labeled thymocytes in rag2-GFP transgenic larvae (Figure 2A-C) . All eight rag2-GFP fish irradiated at 6 dpf exhibited a complete loss of GFP-labeled thymocytes by 8 dpf ( Figure 2B ). By contrast, rag2-EGFP-bcl-2 fish retained GFP-labeled thymocytes following -irradiation (n = 8, Figure   2E ). Similar results were observed in 10-week-old adult fish, with loss of GFP-expressing thymocytes in rag2-GFP fish by 4 days post-irradiation treatment, while T cells within the thymus of rag2-EGFP-bcl-2 transgenic fish survived (Figure 3) . Seven of 8 rag2-GFP transgenic fish treated with dexamethasone (100 µg/ml) lost GFP-labeled thymocytes by 8 dpf ( Figure 2C ). By contrast, all rag2-EGFP-bcl-2 larvae retained GFP-labeled thymocytes (n = 8 per treatment, Figure 2F ), even after treatment with 250 µg/ml dexamethasone.
To determine whether the loss of irradiated thymocytes from rag2-GFP transgenic fish was due to apoptosis, we irradiated 10-week-old rag2-GFP and rag2- 
Expression of EGFP-bcl-2 in the lymphoid compartment results in increased T-and B-cell populations
Fluorescent microscopic analysis showed that the thymus was enlarged in rag2-EGFP-bcl-2 transgenic fish when compared to rag2-GFP control fish (Figure 4 ). The increase in thymus size was accounted for by an increase in total number of thymocytes.
Dissected thymi from 10-week-old rag2-EGFP-bcl-2 fish had increased numbers of thymocytes when compared to rag2-GFP control fish (3.4 +/-1.8 million compared to 1.4 +/-0.5, n = 6, p = 0.02).
T-cell development in rag2-EGFP-bcl-2 fish was also perturbed. Previously, we identified two distinct populations of T cells in the thymus based on size. 39 
FACS analysis indicated that rag2-EGFP-bcl-2 fish have increased numbers of small
lymphocytes when compared to rag2-GFP fish (79.4 +/-3.6% and 70.5+/-6.4%, respectively, n = 6, p = 0.02) and a concomitant decrease in large T cells ( Figure 5 ).
Taken together these results suggest that T-cell development may be perturbed in rag2-EGFP-bcl-2 fish, with T cells possibly arresting at a stage during which cell division is suppressed or at a stage of development marked by decreased cell size.
The kidney is the site of definitive hematopoiesis in adult zebrafish and where Bcell development occurs. 25, 26, 39 Since the rag2-promoter is expressed by both thymocytes and by B cells in adult zebrafish kidney marrow, we reasoned that B-cell development might be altered in rag2-EGFP-bcl-2 transgenic fish. B cells in the kidney cannot be visualized by fluorescent microscopy in undissected living fish because the kidney is positioned deep within the animal. Thus, we used FACS analysis and cell counts to assess if B-cell populations were altered in the rag2-EGFP-bcl-2 kidney ( Figure 6 ).
Although total cell counts were similar between rag2-EGFP-bcl-2 and rag2-GFP fish (0.74+/-0.26 million compared to 0.55+/-0.14 million, n = 6, p = 0. 19), the lymphoid population of the kidney was significantly increased in rag2-EGFP-bcl-2 fish when compared to rag2-GFP control fish (34.4 +/-6.2% and 26.3 +/-4.7, n = 6, p = 0.03, Figure 6 ). Increased numbers of total lymphoid cells were accompanied by an increase in
GFP-expressing lymphoid cells in rag2-EGFP-bcl-2 transgenic fish when compared to
rag2-GFP control fish (20.0 +/-5.8% and 11.0 +/-3.6, n = 6, p = 0.009, Figure 6 ).
FACS-sorted GFP-positive kidney marrow cell populations were analyzed by RT-PCR to confirm that rag-positive cell populations were B-cell in origin. As described previously for the rag2-GFP transgenic line 39 , GFP-positive cells from rag2-EGFP-bcl-specific kinase, lck (data not shown). Taken together, these results indicate that B-cell populations are expanded in the kidney of rag2-EGFP-bcl-2 transgenic fish.
bcl-2 expression blocks irradiation-sensitivity of Myc-induced T-cell leukemias
Myc-induced leukemias in the mouse require suppression of apoptosis which usually occurs by either loss of p53 or ARF, or upregulation of Mdm2. 41 However, it is not known if these transforming mechanisms are present in zebrafish T-ALLs. In order to assess whether the p53 DNA damage pathway is intact in Myc-induced T-ALL in the zebrafish, we irradiated fish that were transplanted with leukemic cells from our rag2-EGFP-mMyc stable transgenic fish (described in Langenau et al, 2003) . Zebrafish thymocytes can be ablated by either irradiation or dexamethasone treatment, 39 however, it is unknown if these processes can be inhibited by disrupting the apoptotic machinery within the zebrafish thymocyte. For example, irradiation-induced apoptosis can be suppressed by either loss of p53 or the overexpression of Bcl-2 in mouse thymocytes. 45, 46 In contrast, dexamethasone-induced apoptosis cannot be inhibited in p53-deficient thymocytes, 45 however, bcl-2 overexpression can suppress dexamethasoneinduced cell death. 46, 47 These experiments indicate that the molecular mechanisms initiating apoptosis in T cells can be markedly different depending upon the source and type of cell damage. Our experiments show that thymocytes from larval rag2-EGFP-bcl-2 fish survive following irradiation or dexamethasone treatment whereas thymocytes from rag2-GFP zebrafish larvae die in response to either treatment. Additional experiments utilizing p53-deficient zebrafish embryos will be required to test whether apoptotic responses to either dexamethasone or irradiation are mediated by the p53 pathway.
To confirm that T cell loss was due to apoptosis following -irradiation, we analyzed thymocytes from transgenic adult fish for AnnexinV-staining following 
12,48
Not only is the relative percentage of small thymocytes altered in rag2-EGFPbcl-2 fish, but the total lymphoid cell number in both the thymus and kidney marrow differs as well. In fact, the thymus is enlarged in rag2-EGFP-bcl-2 fish, having a 2.5
fold-increase in total thymocyte number than when compared to rag2-GFP transgenic observed leukemia or lymphoma in our rag2-EGFP-bcl-2 transgenic zebrafish is that the latency of disease may be very long. Very few of these transgenic fish have been raised past one year of age. Given that B-and T-cell lymphomas in Bcl-2 transgenic mice take a long time to develop (mean latency of 17 months and 18 months, respectively), 14, 15 it is possible that our rag2-EGFP-bcl-2 fish may still develop disease over time.
Myc-induced ALL in the mouse requires suppression of apoptosis, which commonly results from loss of ARF or p53, or upregulation of Mdm-2, 41, 52 and Myc and Bcl-2 have been shown to collaborate in leukmogenesis. 53 Given that many of these transforming events act by inhibiting the p53-mediated DNA-damage response pathway, we reasoned that Myc-induced T-ALLs in the zebrafish might be refractory to irradiation treatment. GFP-labeled Myc tumors could be ablated by irradiation treatment, suggesting that the p53-pathway is likely to be intact in these tumors. Because cycling T lymphoma cells from p53-/-mice undergo apoptosis after irradiation or genotoxic drug treatment and because it is likely that p53 is not the only mediator of apoptosis provoked by DNA damage 54 , we sequenced the zebrafish p53 gene locus, but failed to identify any p53 mutations in Myc-induced T-ALLs (n = 13, S.B. and A.T.L., unpublished data). These results indicate that mutation of p53 is not a frequent event in T-cell transformation in the zebrafish model. In contrast, EGFP-bcl-2 expressing Myc-induced leukemias fail to undergo apoptosis following irradiation treatment, as has been reported in mouse T cell lymphomas that overexpress Bcl-2 54 . Given that the teleost fishes lack the ARF locus, 55 it is possible that Myc upregulation may not induce apoptosis through the p53 pathway, as has been observed in mice and humans. 41, [56] [57] [58] Further studies will be required to 
